SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-324391
Filing Date
2013-08-07
Accepted
2013-08-07 16:49:49
Documents
10
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d544517d10q.htm 10-Q 542728
2 EX-31.1 d544517dex311.htm EX-31.1 8045
3 EX-31.2 d544517dex312.htm EX-31.2 8031
4 EX-32.1 d544517dex321.htm EX-32.1 4159
  Complete submission text file 0001193125-13-324391.txt   4538049

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT geva-20130630.xml EX-101.INS 435769
6 XBRL TAXONOMY EXTENSION SCHEMA geva-20130630.xsd EX-101.SCH 33876
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE geva-20130630_cal.xml EX-101.CAL 50329
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE geva-20130630_def.xml EX-101.DEF 70433
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE geva-20130630_lab.xml EX-101.LAB 255710
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE geva-20130630_pre.xml EX-101.PRE 170419
Mailing Address 33 HAYDEN AVE. LEXINGTON MA 02421
Business Address 33 HAYDEN AVE. LEXINGTON MA 02421 (781) 357-9900
SYNAGEVA BIOPHARMA CORP (Filer) CIK: 0000911326 (see all company filings)

IRS No.: 561808663 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23155 | Film No.: 131018271
SIC: 2836 Biological Products, (No Diagnostic Substances)